Emerging MedTech Innovation Program:
Advanced Clinical Trial Solutions Made Accessible
Your vision is to enhance patient care through innovative devices and diagnostics, striving for market approval after significant investment in product development. Our goal is to make cutting-edge clinical research solutions more accessible to help accelerate your innovation. This program is designed for emerging MedTech companies with less than 50 employees.
Program Overview
Medidata understands the specific obstacles faced by up-and-coming MedTech firms. Medidata’s commitment is to expedite your journey from product development to market launch through a tailored clinical trial solutions package that fits both your needs and budget.
Streamlined Study Start
Streamlined study-build packages designed to accelerate study start
Tailored Pricing Models
Pricing models aligned with emerging MedTech study and budget requirements
Regulatory Best Practices
Rigorous adherence to best practices in regulatory compliance
Promotional Opportunity
Opportunity for joint promotional activities to enhance market visibility
Strategic Partnership
Strategic partnerships to strengthen your MedTech research
Industry Expertise
Dedicated team of industry veterans and experts
“What we liked about the Medidata platform was the ability for us to better manage our clinical studies with improved oversight and reporting capabilities.”
“We looked for reputation, scalability, and a complete platform approach for all stakeholders, and found that with Medidata eTMF, Rave EDC, and Payments.”
Achieve Clinical, Regulatory, and Long-Term Success with Medidata
With over two decades of continuous digital innovation and leadership, Medidata is a trusted leader in this space. Here’s a snapshot of Medidata’s track record with MedTech companies:
Trials
We’ve conducted with 810+ Medical Device and Diagnostic Trials
MedTech Sponsors
Collaborated with 194 distinct MedTech Sponsors
MedTech Sites
Supported operations across 21,300 MedTech Sites
Participants
Served 400,000 participants during their Device and Diagnostic Trials
Contact Us
Ready to transform your clinical trials? Get in touch with us today to get started.